Fig. 2.

Decreased weight gain in the cyclopentolate group compared to placebo and control groups. Mean weight of mice at baseline and 7 days after ophthalmic administration. Despite similar weights at baseline, mice in the control and placebo groups showed a tendency to have higher weight gain each day following drop administration compared to the cyclopentolate group, with statistically significant differences in weight seen on days 3 and 7 (* p < 0.05, n = 9 per group).